- In vivo antitumor activity of S16020, a topoisomerase II inhibitor, and doxorubicin against human brain tumor xenografts. Vassal, G., Merlin, J.L., Terrier-Lacombe, M.J., Grill, J., Parker, F., Sainte-Rose, C., Aubert, G., Morizet, J., Sévenet, N., Poullain, M.G., Lucas, C., Kalifa, C. Cancer Chemother. Pharmacol. (2003)